{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:42:01Z","timestamp":1783539721497,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.dld.2013.03.005","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T00:13:28Z","timestamp":1366157608000},"page":"733-737","source":"Crossref","is-referenced-by-count":13,"title":["How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study"],"prefix":"10.1016","volume":"45","author":[{"given":"Fernando","family":"Bermejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Algaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Taxonera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Garc\u00eda-Arata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier P.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"de-la-Poza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"L\u00f3pez-Sanrom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2013.03.005_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"Journal of Crohn's Colitis"},{"key":"10.1016\/j.dld.2013.03.005_bib0010","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0015","series-title":"Targeted tuberculin testing and treatment of latent TB infection. ATS guidelines","author":"American Thoracic Society","year":"1999"},{"key":"10.1016\/j.dld.2013.03.005_bib0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing M TB infection and disease in patients due to start anti-TNF alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.dld.2013.03.005_bib0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1157\/13083915","article-title":"Recommendations on tuberculosis and treatment of inflammatory bowel disease with infliximab. 2006 update","volume":"29","author":"L\u00f3pez-San Rom\u00e1n","year":"2006","journal-title":"Gastroenterologia y Hepatologia"},{"key":"10.1016\/j.dld.2013.03.005_bib0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/gut.2005.076034","article-title":"Preventing TB in patients with Crohn's disease needing infliximab or other anti-TNF therapy","volume":"54","author":"Rampton","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.dld.2013.03.005_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2036.2007.03553.x","article-title":"Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease","volume":"27","author":"Theis","year":"2008","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.dld.2013.03.005_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2013.03.005_bib0050","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"G\u00f3mez-Reino","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.dld.2013.03.005_bib0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1542-3565(04)00060-6","article-title":"High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy","volume":"2","author":"Mow","year":"2004","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0060","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.1572-0241.2008.02050.x","article-title":"Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease","volume":"103","author":"Schoepfer","year":"2008","journal-title":"American Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.03.005_bib0065","first-page":"474","article-title":"Infliximab does not suppress the tuberculin skin test (purified protein derivative)","volume":"34","author":"Hatemi","year":"2007","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/ibd.21329","article-title":"Quantiferon\u00ae TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States","volume":"17","author":"Qumseya","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"issue":"Suppl.","key":"10.1016\/j.dld.2013.03.005_bib0075","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"170","author":"Lennard-Jones","year":"1989","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2013.03.005_bib0080","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/j.rmed.2006.02.032","article-title":"Diagnosis of latent TB infection: the potential role of new technologies","volume":"100","author":"Kunst","year":"2006","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0085","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0090","series-title":"Tuberculosis surveillance and monitoring in Europe 2012","author":"European Centre for Disease Prevention and Control\/WHO Regional Office for Europe","year":"2012"},{"key":"10.1016\/j.dld.2013.03.005_bib0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0100","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0105","doi-asserted-by":"crossref","first-page":"R114","DOI":"10.1186\/ar1994","article-title":"Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists","volume":"8","author":"Hamdi","year":"2006","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.dld.2013.03.005_bib0110","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ibd.21602","article-title":"Does anti-TNF therapy influence the performance of mycobacterium tuberculosis antigen-specific interferon-gamma assays? A French multicenter experience","volume":"17","author":"Del Tedesco","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0115","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay","volume":"67","author":"Matulis","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0120","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0b013e3283474d62","article-title":"Interferon-\u03b3 release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders","volume":"23","author":"Smith","year":"2011","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0125","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.3899\/jrheum.090150","article-title":"Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial","volume":"36","author":"Park","year":"2009","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0130","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.23705","article-title":"Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy","volume":"59","author":"Chen","year":"2008","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.dld.2013.03.005_bib0135","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10067-008-1007-9","article-title":"Repeated tuberculin skin testing following therapy with TNF-alpha inhibitors","volume":"28","author":"Fuchs","year":"2009","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ard.2005.040055","article-title":"Does anti-tumour necrosis factor alpha treatment modify the tuberculin PPD response?","volume":"65","author":"Joven","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0145","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1469-0691.2011.03555.x","article-title":"Guidelines on interferon-\u03b3 release assays for tuberculosis infection: concordance, discordance or confusion?","volume":"17","author":"Denkinger","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.dld.2013.03.005_bib0150","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.4049\/jimmunol.167.9.5217","article-title":"Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment","volume":"167","author":"Pathan","year":"2001","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.dld.2013.03.005_bib0155","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ibd.21427","article-title":"Factors impacting the results of interferon-\u03b3 release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases","volume":"17","author":"Papay","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0160","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s10096-008-0519-1","article-title":"Performance of two commercial blood IFN-gamma release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-alpha treatment","volume":"27","author":"Bocchino","year":"2008","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0165","first-page":"1177","article-title":"Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers","volume":"11","author":"Cobanoglu","year":"2007","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.dld.2013.03.005_bib0170","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"Ponce de Leon","year":"2008","journal-title":"Journal of Rheumatology"},{"key":"10.1016\/j.dld.2013.03.005_bib0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/apt.12037","article-title":"Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-\u03b1 inhibitors","volume":"36","author":"Papay","year":"2012","journal-title":"Alimentary Pharmacology and Therapeutics"},{"key":"10.1016\/j.dld.2013.03.005_bib0180","doi-asserted-by":"crossref","unstructured":"Ramos JM, Masi\u00e1 M, Rodr\u00edguez JC, et al. Negative effect of immunosuppressive therapy in the performance of the QuantiFERON Gold In-tube test in patients with immune-mediated inflammatory diseases. Clin Exp Med; in press.","DOI":"10.1007\/s10238-012-0192-7"},{"key":"10.1016\/j.dld.2013.03.005_bib0185","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/rccm.2506003","article-title":"Interferon gamma assays for TB: is anergy the achilles\u2019 heel?","volume":"172","author":"Madhukar","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0190","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","article-title":"Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of TB infection","volume":"172","author":"Ferrara","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0195","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0200","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ibd.21605","article-title":"Prednisolone treatment affects the performance of the Quantiferon\u00ae gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection","volume":"17","author":"B\u00e9lard","year":"2011","journal-title":"Inflammatory Bowel Diseases"},{"key":"10.1016\/j.dld.2013.03.005_bib0205","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.crohns.2011.09.011","article-title":"Steroid treatment and further combination therapy with immunosuppressive agents lead to a high risk of indeterminate Quantiferon\u00ae test","volume":"6","author":"Helwig","year":"2012","journal-title":"Journal of Crohn's Colitis"},{"key":"10.1016\/j.dld.2013.03.005_bib0210","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/JCM.00482-10","article-title":"Immediate incubation reduces indeterminate results for Quantiferon\u00ae-TB Gold in-tube assay","volume":"48","author":"Herrera","year":"2010","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.dld.2013.03.005_bib0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1378\/chest.11-3157","article-title":"Predictive value of interferon-gamma release assays and tuberculin skin testing for predicting progression from latent TB infection to disease state: a meta-analysis","volume":"142","author":"Diel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.dld.2013.03.005_bib0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","article-title":"Negative and positive predictive value of a whole-blood IGRA for developing active TB \u2013 an update","volume":"183","author":"Diel","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0225","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.00098509","article-title":"Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts","volume":"35","author":"Kik","year":"2010","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.dld.2013.03.005_bib0230","first-page":"125","article-title":"Position statement on interferon-\u03b3 release assays in the detection of latent tuberculosis infection","volume":"36","author":"National Tuberculosis Advisory Committee Australia","year":"2012","journal-title":"Communicable Diseases Intelligence"},{"key":"10.1016\/j.dld.2013.03.005_bib0235","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/art.21734","article-title":"The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities: a large, randomized, placebo-controlled trial","volume":"54","author":"Westhovens","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.dld.2013.03.005_bib0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","article-title":"Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing","volume":"180","author":"van Zyl-Smit","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.dld.2013.03.005_bib0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","article-title":"A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements","volume":"57","author":"Wang","year":"2002","journal-title":"Thorax"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865813001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T23:57:06Z","timestamp":1539734226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865813001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1590865813001035"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2013.03.005","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}